Q32 Bio Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-4.3% vs price
Base Case (Median)
66.5% vs price
Bull Case (75th pct.)
306.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $4.96 | -67.5% | High (40%) |
| PE Comparable | $62.09 | 306.1% | Medium (25%) |
| Graham Number | $14.64 | -4.2% | Medium (40%) |
| EV/EBITDA | $25.46 | 66.5% | Medium (20%) |
| Earnings Power Value | $69.47 | 354.4% | Medium (50%) |
Based on 5 out of 8 methods, QTTB appears fairly valued at the current price of $15.29. The base case fair value of $25.46 implies 66.5% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.